2021
Overcoming the Patent Gap: A Guide to Patenting for Plastic Surgeons
Kisyova R, Kannan R, Nadkarni P, Chandawarkar R. Overcoming the Patent Gap: A Guide to Patenting for Plastic Surgeons. Plastic & Reconstructive Surgery 2021, 148: 908-917. PMID: 34550948, DOI: 10.1097/prs.0000000000008369.Peer-Reviewed Original Research
2018
Hal O. Anger, DSc (hon) (1920-2005)
Wackers FJT, Corner O. Hal O. Anger, DSc (hon) (1920-2005). Journal Of Nuclear Cardiology 2018, 26: 372-373. PMID: 30051346, DOI: 10.1007/s12350-018-1384-7.Peer-Reviewed Original ResearchThe Impact of Off-Patent Drug Acquisitions on Prices
Gupta R, Henkel A, Forman HP, Ross JS. The Impact of Off-Patent Drug Acquisitions on Prices. Journal Of General Internal Medicine 2018, 33: 1007-1009. PMID: 29687433, PMCID: PMC6025665, DOI: 10.1007/s11606-018-4372-3.Peer-Reviewed Original ResearchAffordability and availability of off-patent drugs in the United States—the case for importing from abroad: observational study
Gupta R, Bollyky TJ, Cohen M, Ross JS, Kesselheim AS. Affordability and availability of off-patent drugs in the United States—the case for importing from abroad: observational study. The BMJ 2018, 360: k831. PMID: 29555641, PMCID: PMC5858606, DOI: 10.1136/bmj.k831.Peer-Reviewed Original ResearchConceptsOff-patent drugsObservational studyRare diseasePrescription drugsPatent drugsStudy drugTotal Medicaid spendingCardiovascular diseaseOrphan drug designationPsychiatric diseasesDrug AdministrationPatient accessInfectious diseasesDiseaseDrug characteristicsEssential medicinesDrugsGeneric versionsGeneric drugsMedicaid spendingNovel tabletRegulatory agenciesFDAUnited StatesTreatment areaPediatric Exclusivity and Regulatory Authority: Implications of Amgen v HHS
Kim J, Ross JS, Kapczynski A. Pediatric Exclusivity and Regulatory Authority: Implications of Amgen v HHS. JAMA 2018, 319: 21-22. PMID: 29117365, DOI: 10.1001/jama.2017.16477.Commentaries, Editorials and Letters
2016
Chemical named entity recognition in patents by domain knowledge and unsupervised feature learning
Zhang Y, Xu J, Chen H, Wang J, Wu Y, Prakasam M, Xu H. Chemical named entity recognition in patents by domain knowledge and unsupervised feature learning. Database 2016, 2016: baw049. PMID: 27087307, PMCID: PMC4834204, DOI: 10.1093/database/baw049.Peer-Reviewed Original ResearchConceptsMachine learning-based systemsLearning-based systemConditional Random FieldsDomain knowledgeEntity recognitionMatthews correlation coefficientDrug Named Entity RecognitionBioCreative V challengeInformation extraction systemWord representation featuresUnsupervised feature learningUnsupervised learning algorithmNamed Entity RecognitionSemantic type informationSupport vector machinePrecision-recall curveBrown clusteringFeature learningFeature engineeringUnsupervised featureIndividual subtasksMining systemNER taskLearning algorithmCPD task
2011
Response to Open Peer Commentaries on “Social Contexts Influence Ethical Considerations of Research”
Levine RJ, Gordon JB, Mazure CM, Rubin PE, Schaller BR, Young JL. Response to Open Peer Commentaries on “Social Contexts Influence Ethical Considerations of Research”. The American Journal Of Bioethics 2011, 11: w1-w2. PMID: 21534134, DOI: 10.1080/15265161.2011.576936.Peer-Reviewed Original Research
2010
Opening Up to Precompetitive Collaboration
Altshuler JS, Balogh E, Barker AD, Eck SL, Friend SH, Ginsburg GS, Herbst RS, Nass SJ, Streeter CM, Wagner JA. Opening Up to Precompetitive Collaboration. Science Translational Medicine 2010, 2: 52cm26. PMID: 20926831, DOI: 10.1126/scitranslmed.3001515.Peer-Reviewed Original Research
2002
Patently Controversial: Markets, Morals, and the President's Proposal for Embryonic Stem Cell Research
Fins J, Schachter M. Patently Controversial: Markets, Morals, and the President's Proposal for Embryonic Stem Cell Research. Kennedy Institute Of Ethics Journal 2002, 12: 265-278. PMID: 12472079, DOI: 10.1353/ken.2002.0016.Peer-Reviewed Original Research
2001
Investigators, industry, and the heuristic device: Ethics, patent law, and clinical innovation
Fins J, Schachter M. Investigators, industry, and the heuristic device: Ethics, patent law, and clinical innovation. Accountability In Research 2001, 8: 219-233. PMID: 12481768, DOI: 10.1080/08989620108573975.Peer-Reviewed Original ResearchBiomedical ResearchBrainClinical Trials as TopicConflict of InterestDisclosureElectric Stimulation TherapyElectrodes, ImplantedEntrepreneurshipEthical ReviewEthics, MedicalHumansIndustryInformed ConsentInterprofessional RelationsPatents as TopicPhysiciansResearch PersonnelResearch Support as TopicSurgical EquipmentSurgical Procedures, OperativeUnited States
1997
Proposed model ethical protocol for collecting DNA samples.
Weiss K, Cavalli-Sforza L, Dunston G, Feldman M, Greely H, Kidd K, King M, Moore J, Szathmary E, Twinn C. Proposed model ethical protocol for collecting DNA samples. 1997, 33: 1431-74. PMID: 12627556.Peer-Reviewed Original ResearchBlood Specimen CollectionConfidentialityCultural DiversityDelivery of Health CareDNAEthics, ResearchGenetic PrivacyGenetic ResearchGenetic VariationGenetics, PopulationGuidelines as TopicHuman Genome ProjectHuman RightsHumansIndians, North AmericanInformed ConsentInternationalityOwnershipPatents as TopicPatient ParticipationResearch SubjectsSpecimen HandlingThird-Party Consent
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply